Gestructureerd farmacotherapie overleg: Een kosteneffectief middel om naleven van medicamenteuze richtlijnadviezen te bevorderen?

Pharmacotherapy audit meetings (PTAMs) using quality circles: A cost-effective strategy to improve guideline adherence in nursing homes?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25825

Enrollment

Registered

2011-03-10

Start date

2011-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleepdisorders behavioral problems dementia

Interventions

Implementation of working with quality circles at level 3 or 4 in already existing pharmacotherapy audit meetings (PTAMs). PTAMs of the intervention group will be trained and intensively supported in

Eligibility

Inclusion criteria

Inclusion criteria: Pharmacotherapy audit meetings (PTAMs) in Dutch nursing homes not using quality circles or working with quality circles functioning at level 1 or 2.

Exclusion criteria

Exclusion criteria: Pharmacotherapy audit meetings (PTAMs) already working with quality circles and functioning on level 3 or 4.

Design outcomes

Secondary

Measure	Time frame
1. Scores on other prescriptionindicators (chosen drug, dosage, treatment time) of residents of participating pharmacotherapy counselling groups; 2. Experienced workload/worksatisfaction of participating pharmacotherapy counselling group members; 3. Falls, hospital admissions and mortality of residents of participating pharmacotherapy counselling groups; 4. Costs (hospital admissions, falls, medication, intervention); 5. Use of other psychotropics drugs by residents of participating pharmacotherapy counselling groups; 6. Use of physical restriants by residents of participating pharmacotherapy counselling groups.	—

Measure

Time frame

1. Scores on other prescriptionindicators (chosen drug, dosage, treatment time) of residents of participating pharmacotherapy counselling groups; 2. Experienced workload/worksatisfaction of participating pharmacotherapy counselling group members; 3. Falls, hospital admissions and mortality of residents of participating pharmacotherapy counselling groups; 4. Costs (hospital admissions, falls, medication, intervention); 5. Use of other psychotropics drugs by residents of participating pharmacotherapy counselling groups; 6. Use of physical restriants by residents of participating pharmacotherapy counselling groups.

—

Primary

Measure	Time frame
Percentage of residents of the physicians/nursing homes of pharmacotherapy counselling groups that using: 1. Hypnotics; 2. Antipsychotics.	—

Contacts

Public ContactMartin Smalbrugge

Department of Nursing Home Medicine, the EMGO Institute for Health and Care Research, VU University Medical Center De Boelelaan 1109 / 9A-03

m.smalbrugge@vumc.nl+31 (0)20 4449686

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)